CONTI, Pio
 Distribuzione geografica
Continente #
NA - Nord America 8.740
AS - Asia 6.007
EU - Europa 5.891
SA - Sud America 619
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 7
Totale 21.365
Nazione #
US - Stati Uniti d'America 8.562
SG - Singapore 2.283
CN - Cina 1.732
UA - Ucraina 1.054
IE - Irlanda 834
GB - Regno Unito 791
TR - Turchia 782
SE - Svezia 697
RU - Federazione Russa 628
BR - Brasile 516
IT - Italia 510
VN - Vietnam 487
DE - Germania 482
FR - Francia 464
IN - India 383
FI - Finlandia 224
CA - Canada 115
HK - Hong Kong 76
AR - Argentina 55
MX - Messico 45
PL - Polonia 43
BD - Bangladesh 38
ES - Italia 37
KR - Corea 36
ZA - Sudafrica 34
JP - Giappone 32
BE - Belgio 31
CZ - Repubblica Ceca 31
IQ - Iraq 25
IL - Israele 17
IR - Iran 17
EU - Europa 14
EC - Ecuador 13
NL - Olanda 13
ID - Indonesia 12
UZ - Uzbekistan 12
CL - Cile 11
KE - Kenya 11
LT - Lituania 11
PK - Pakistan 10
RO - Romania 9
SA - Arabia Saudita 9
TN - Tunisia 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
EG - Egitto 7
CO - Colombia 6
PH - Filippine 6
AU - Australia 5
DZ - Algeria 5
MY - Malesia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
GR - Grecia 4
JO - Giordania 4
MA - Marocco 4
MD - Moldavia 4
OM - Oman 4
TT - Trinidad e Tobago 4
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
KZ - Kazakistan 3
ML - Mali 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EE - Estonia 2
GY - Guiana 2
IM - Isola di Man 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
SN - Senegal 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
Totale 21.355
Città #
Singapore 1.682
Chandler 1.130
Jacksonville 1.113
San Jose 860
Dublin 824
Southend 531
Ashburn 518
Dallas 416
Princeton 392
Beijing 389
Izmir 373
Nanjing 322
Dearborn 227
Wilmington 223
Los Angeles 199
Santa Clara 188
Cambridge 187
Ho Chi Minh City 176
Ann Arbor 168
The Dalles 155
Altamura 151
Tongling 130
Boardman 124
Buffalo 114
Nanchang 112
New York 111
Hanoi 108
Munich 106
Woodbridge 95
Council Bluffs 87
Grevenbroich 73
Shenyang 73
Moscow 71
Chieti 70
Hong Kong 63
Houston 62
São Paulo 62
Hebei 59
Tianjin 52
Jiaxing 46
Washington 44
Jinan 42
Kunming 40
Montréal 37
Chennai 35
Denver 33
Orem 33
Seoul 33
Redondo Beach 32
Augusta 30
Warsaw 30
Brooklyn 29
Tokyo 29
Pescara 28
Brussels 27
Chicago 27
Da Nang 27
Hangzhou 27
Johannesburg 27
Brno 26
Helsinki 26
Montreal 26
Boston 25
Norwalk 25
Orange 25
San Mateo 24
Turku 24
Atlanta 23
Mcallen 23
Ningbo 22
Toronto 22
Zhengzhou 22
Hefei 21
Haiphong 20
London 20
Changsha 19
Mexico City 18
Seattle 18
Auburn Hills 17
Manchester 17
Poplar 17
Stockholm 17
Dong Ket 16
Phoenix 16
Belo Horizonte 15
Frankfurt am Main 15
Düsseldorf 14
Guangzhou 14
Hyderabad 14
Brasília 13
Taizhou 13
Mumbai 12
Pune 12
Rio de Janeiro 12
Rome 12
San Francisco 12
Bangalore 11
Biên Hòa 11
Cepagatti 11
Fairfield 11
Totale 13.183
Nome #
Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw. 248
Vascular endothelial growth factor (VEGF), mast cells and inflammation 188
Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1β levels and expression in peripheral blood mononuclear cells 175
5-HT and histamine release from rat basophilic leukemia cells treated or non with IL-1RA 175
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 173
Allergen immunotherapy: an effective immune-modifier. 170
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 169
Analytical Management of Patients Undergoing Oral Anticoagulant Therapy Could Have a Strong Impact on Clinical Outcomes: A Follow-up Study 169
Anti-chemochine therapy for inflammatory diseases 168
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 168
Caffeine, Theophylline and bamifylline are similar as competitive inhibitors of 3' ,5'-cyclic AMP phosphodiesterase in vitro 164
Augmentation of monocyte chemotactic protein-1 (MCP-1) and mRNA Transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo 164
Heme Oxigenase-1 (HO-1) and oxidative stress in rat heart 160
A scavenger role for nitric oxide in the aged rat kidney. 158
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 158
A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application 157
Nutrition and cancer prevention. 156
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 155
Bamifylline similar to theophylline and caffeine is a competitive inhibitor of the cyclic nucleotide phosphodiesterase V 153
Activation and inhibition of adaptive immune response mediated by mast cells 151
Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines 151
Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related 150
Microarray expression profiling of human dental pulp from single subject. 149
Differential TBXA2 receptor transcript stability is dependent on the C924T polymorphism 149
Synergistic activation of serum amyloid a (saa) by il - 6 and il - 1 in combination on human hep 3 b hepatoma cell line. Role of pge2 and il-1 receptor antagonist 146
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 146
A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy. 146
ENOX2 (or tNOX): a new and old molecule with cancer activity involved in tumor prevention and therapy 145
Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37 145
Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis. 144
Endocrinology of the skin: intradermal neuroimmune network, a new frontier 140
Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury 140
Interleukin-9 and mast cells 139
Interferon β1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis 138
Monocyte chemotactic protein 1 (MCP-1) activates mast cells to aggregate and release [3H]-5HT 136
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 136
ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY 136
Effect of electromagnetic fields on several CD markers and transcription and expression of CD4 136
Comparison of Serum Total Valproic Acid Levels and %CDT Values in Chronic Alcohol Addictive Patients in an Italian Clinic: A Retrospective Study 135
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 135
Calcium ionophore A23187 and compound 48/80 induce PGD2 and tryptase in human cord blood-derived mast cells: lack of effect of il-18 134
In vitro effects of vanadate on human immune functions 134
A new diagnostic approach to better identify antiphospholipid syndrome. 133
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 133
IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation 132
IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines 132
Neuropeptide substance P induces mRNA expression and secretion of CXCL8 chemokine, and HDC in human umbilical cord blood mast cells. 131
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 131
Chemokines as markers for parasite-induced inflammation and tumors 130
Interleukin-17 and the interleukin-17 family member network. 130
Tridimensional response of human dental follicular stem cells onto a synthetic hydroxyapatite scaffold. 130
Different effects of platinum, palladium, and rhodium salts on lymphocyte proliferation and cytokine release 130
Impact of RANTES, MCP-1 and IL-8 in mast cells 129
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 129
Monocyte Chemotactis Protein-1 Gene Expression and Translation in Formed Granulomatous Calcified Tissue in Vivo 129
IL-10, an inflammatory/inhibitory cytokine, but not always. 128
Morphostructural analysis of human follicular stem cells on highly porous bone hydroxyapatite scaffold. 128
Relevance of plant lectins in human cell biology and immunology 128
Massive infiltration of basophilic cells in inflamed tissue after injection of RANTES. 126
Production of cytokines in trichinellosis infected mice 125
Effect of the compound L-mimosine in an in vivo model of chronic granuloma formation induced by potassium permanganate (KMNO4). 125
Modulation of MCP-1 and iNOS by 50 Hz sinusoidal electromagnetic field 124
IL-36 a new member of the IL-1 family cytokines 124
Effect of chronic hypoxia on inducible nitric oxide synthase expression in rat myocardial tissue 123
The down-regulation of il-6-stimulated fibrinogen steadu state mrna and protein levels by human recombinant il-1 is not pge2-dependent:effects of il-1 receptor antagonist (il-1ra) 122
Cytokines and allergic disorders: a revisited study 122
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 122
Effect of interleukin-1 receptor antagonist (IL-1RA) on histamine and serotonin release by rat basophilic leukemia cells (RBL-2H3) and peritoneal mast cells 122
IL-32: a newly-discovered proinflammatory cytokine 122
L-carnitine enhances adenosine triphosphate (ATP) and inhibits lymphocite proliferation 121
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 120
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 120
Impact of IL-32 on histamine release by human derived umbilical cord blood mast cells 120
Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. 120
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 119
Detection of nuclear and membrane antigens by liquid-based cytology following long-term storage of d1 cells, karpas cells, and peripheral blood mononuclear cells. 119
Interleukin-17: a revisited study. 119
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 118
Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2(PGE) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4 118
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 118
Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. 118
Endothelial Nitric Oxide Synthase (e-NOS)expression and localization in healthy and diabetic rat hearts 118
Substance P upregulates LTB4 in rat adherent macrophages from granuloma induced by KMnO4 118
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 117
Aluminum impairs rat neural cell mitochondria in vitro 117
Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine. 117
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 117
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 115
Infections and mast cells 115
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 114
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 114
Will MCP-1 and RANTES take center stage in inflammatory diseases including asthma? 113
Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee 113
Periodontitis and cytokine patterns in HIV positive patients 113
IL-1beta induces alkaline phosphatase in human phagocytes 112
Irritable bowel syndrome and bronchial hyperresponsiveness: is there a link? 110
Endothelial NOS expression and ischemia- reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions 110
Vitamin B6-deficient diet plus 4-deoxypyridoxine (4-DPD) reduces the inflammatory response induced by T. spiralis in diaphragm, masseter and heart muscle tissue of mice 110
Advances in therapy with antileukotriene drugs. 110
Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. 109
Totale 13.521
Categoria #
all - tutte 79.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021328 0 0 0 0 0 0 0 0 0 183 60 85
2021/2022789 28 13 4 166 64 3 16 64 54 26 104 247
2022/20232.982 258 380 181 360 328 587 162 194 373 34 62 63
2023/20241.135 95 40 66 38 63 314 313 37 19 21 13 116
2024/20253.225 234 596 579 59 69 89 47 148 281 139 364 620
2025/20265.907 539 312 752 736 568 469 1.052 445 638 396 0 0
Totale 21.891